EDITORIAL
Emerging topics in Guillain–Barré syndrome
First published: 27 August 2021
No abstract is available for this article.
DISCLOSURE
Conflict of interest: The author declares no conflict of interest.
REFERENCES
- 1Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016; 388: 717–27.
- 2Koga M, Kishi M, Fukusako T, Kanda T. Distal limb weakness phenotype of Guillain-Barré syndrome. J Neurol Sci. 2018; 392: 83–8.
- 3Uchibori A, Gyohda A, Chiba A. Ca(2+)-dependent anti-GQ1b antibody inGQ1b-seronegative Fisher syndrome and related disorders. J Neuroimmunol. 2016; 298: 172–7.
- 4Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020; 143: 3104–20.
- 5FDA NEWS RELEASE. Coronavirus (COVID-19) Update: July 13, 2021. [cited 2021 Jul 17]. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-13-2021
